Global Therapeutic Drug Monitoring (TDM) Market - Forecasts From 2018 to 2023
The global therapeutic drug monitoring market is projected to grow at a CAGR of 6.49%, increasing from US$1.457 billion in 2017 to US$2.125 billion in 2023. Therapeutic Drug Monitoring (TDM) is the measurement of the specific drugs in patient’s bloodstream at selected intervals, thereby, helping to optimize individual dosing regimen. TDM is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. TDM aims to use and optimize appropriate concentrations of difficult-to-manage medications to enable the assessment of the efficacy and safety of the medication in a variety of clinical settings. The market is expected to show a significant growth during the given period. The rising demand of therapeutic drug monitoring in the administration of the personalized medicines as well as in the areas of drug discovery, clinical research, and biomarker validation is driving the growth of the market. However, limited number of drugs that are amenable to therapeutic drug monitoring and laboratory variability in reporting the results might hamper the growth of the market during the given forecast period.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global therapeutic drug monitoring market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global therapeutic drug monitoring market.
Major industry players profiled as part of the report are Thermo Fisher Scientific, Siemens Healthcare Private Limited and Abbott among others.
Segmentation
By Methodology
Spectrophotometry and Fluorimetry
Chromatography
Radio immuno assay (RIA)
Enzyme Immuno assay
Fluorescence polarization Immunoassay (FPIA)
By Drug Categories
Cardio active drugs
Antibiotics
Antidepressants
Antiepileptic drugs
Bronchodilators
Immunosuppressive
Others
By End Users
Hospitals and Clinics
Diagnostic Centres
Research Institutes
By Geography
North America
United States
Canada
Others
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Australia
South Korea
Others
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global therapeutic drug monitoring market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global therapeutic drug monitoring market.
Major industry players profiled as part of the report are Thermo Fisher Scientific, Siemens Healthcare Private Limited and Abbott among others.
Segmentation
By Methodology
Spectrophotometry and Fluorimetry
Chromatography
Radio immuno assay (RIA)
Enzyme Immuno assay
Fluorescence polarization Immunoassay (FPIA)
By Drug Categories
Cardio active drugs
Antibiotics
Antidepressants
Antiepileptic drugs
Bronchodilators
Immunosuppressive
Others
By End Users
Hospitals and Clinics
Diagnostic Centres
Research Institutes
By Geography
North America
United States
Canada
Others
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Australia
South Korea
Others
1. INTRODUCTION
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. GLOBAL THERAPEUTIC DRUG MONITORING (TDM) MARKET FORECAST BY METHODOLOGY
5.1. Spectrophotometry and Fluorimetry
5.2. Chromatography
5.3. Radio immuno assay (RIA)
5.4. Enzyme Immuno assay
5.5. Fluorescence polarization Immunoassay (FPIA)
6. GLOBAL THERAPEUTIC DRUG MONITORING (TDM) MARKET FORECAST BY DRUG CATEGORIES
6.1. Cardio active drugs
6.2. Antibiotics
6.3. Antidepressants
6.4. Antiepileptic drugs
6.5. Bronchodilators
6.6. Immunosuppressive
6.7. Others
7. GLOBAL THERAPEUTIC DRUG MONITORING (TDM) MARKET FORECAST BY END USERS
7.1. Hospitals and Clinics
7.2. Diagnostic Centres
7.3. Research Institutes
8. GLOBAL THERAPEUTIC DRUG MONITORING (TDM) MARKET FORECAST BY GEOGRAPHY (US$ BILLION)
8.1. North America
8.1.1. The U.S
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. U.K.
8.3.2. France
8.3.3. Germany
8.3.4. Italy
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. UAE
8.4.3. Israel
8.4.4. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. India
8.5.3. Australia
8.5.4. South Korea
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. COMPANY PROFILES
10.1. Abbott
10.1.1. Overview
10.1.2. Financials
10.1.3. Product and Services
10.1.4. Recent Developments
10.2. Thermo Fisher Scientific
10.2.1. Overview
10.2.2. Financials
10.2.3. Product and Services
10.2.4. Recent Developments
10.3. Alpco
10.3.1. Overview
10.3.2. Financials
10.3.3. Product and Services
10.3.4. Recent Developments
10.4. Bio-Rad Laboratories, Inc.
10.4.1. Overview
10.4.2. Financials
10.4.3. Product and Services
10.4.4. Recent Developments
10.5. Siemens Healthcare Private Limited
10.5.1. Overview
10.5.2. Financials
10.5.3. Product and Services
10.5.4. Recent Developments
10.6. Randox Laboratories Ltd.
10.6.1. Overview
10.6.2. Financials
10.6.3. Product and Services
10.6.4. Recent Developments
10.7. Beckman Coulter, Inc.
10.7.1. Overview
10.7.2. Financials
10.7.3. Product and Services
10.7.4. Recent Developments
10.8. Roche Diagnostics
10.8.1. Overview
10.8.2. Financials
10.8.3. Product and Services
10.8.4. Recent Developments
10.9. Pharmaceutical Product Development, LLC
10.9.1. Overview
10.9.2. Financials
10.9.3. Product and Services
10.9.4. Recent Developments
10.10. Chromsystems Instruments & Chemicals GmbH
10.10.1. Overview
10.10.2. Financials
10.10.3. Product and Services
10.10.4. Recent Developments
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. GLOBAL THERAPEUTIC DRUG MONITORING (TDM) MARKET FORECAST BY METHODOLOGY
5.1. Spectrophotometry and Fluorimetry
5.2. Chromatography
5.3. Radio immuno assay (RIA)
5.4. Enzyme Immuno assay
5.5. Fluorescence polarization Immunoassay (FPIA)
6. GLOBAL THERAPEUTIC DRUG MONITORING (TDM) MARKET FORECAST BY DRUG CATEGORIES
6.1. Cardio active drugs
6.2. Antibiotics
6.3. Antidepressants
6.4. Antiepileptic drugs
6.5. Bronchodilators
6.6. Immunosuppressive
6.7. Others
7. GLOBAL THERAPEUTIC DRUG MONITORING (TDM) MARKET FORECAST BY END USERS
7.1. Hospitals and Clinics
7.2. Diagnostic Centres
7.3. Research Institutes
8. GLOBAL THERAPEUTIC DRUG MONITORING (TDM) MARKET FORECAST BY GEOGRAPHY (US$ BILLION)
8.1. North America
8.1.1. The U.S
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. U.K.
8.3.2. France
8.3.3. Germany
8.3.4. Italy
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. UAE
8.4.3. Israel
8.4.4. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. India
8.5.3. Australia
8.5.4. South Korea
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. COMPANY PROFILES
10.1. Abbott
10.1.1. Overview
10.1.2. Financials
10.1.3. Product and Services
10.1.4. Recent Developments
10.2. Thermo Fisher Scientific
10.2.1. Overview
10.2.2. Financials
10.2.3. Product and Services
10.2.4. Recent Developments
10.3. Alpco
10.3.1. Overview
10.3.2. Financials
10.3.3. Product and Services
10.3.4. Recent Developments
10.4. Bio-Rad Laboratories, Inc.
10.4.1. Overview
10.4.2. Financials
10.4.3. Product and Services
10.4.4. Recent Developments
10.5. Siemens Healthcare Private Limited
10.5.1. Overview
10.5.2. Financials
10.5.3. Product and Services
10.5.4. Recent Developments
10.6. Randox Laboratories Ltd.
10.6.1. Overview
10.6.2. Financials
10.6.3. Product and Services
10.6.4. Recent Developments
10.7. Beckman Coulter, Inc.
10.7.1. Overview
10.7.2. Financials
10.7.3. Product and Services
10.7.4. Recent Developments
10.8. Roche Diagnostics
10.8.1. Overview
10.8.2. Financials
10.8.3. Product and Services
10.8.4. Recent Developments
10.9. Pharmaceutical Product Development, LLC
10.9.1. Overview
10.9.2. Financials
10.9.3. Product and Services
10.9.4. Recent Developments
10.10. Chromsystems Instruments & Chemicals GmbH
10.10.1. Overview
10.10.2. Financials
10.10.3. Product and Services
10.10.4. Recent Developments
